OpenVSafe by OpenVAERS
Search V-safe

UUF-25296-04402

3 vaccinations 1 coded response 5 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
977 / OR
Registered
2022-01-31
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-16
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-26
    Dose 3 — Pfizer-BioNTech
  4. 2022-01-31
    Registered in v-safe
  5. 2022-01-31
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Chills, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2022-02-01
    Survey response — days 1–6 daily, dose 3
    MedDRA: Paranasal sinus hypersecretion, Sneezing — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Draining sinus, sneezing
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-02-12
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  8. 2022-02-18
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  9. 2022-07-27
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-21Pfizer-BioNTech No
22021-04-16Pfizer-BioNTech No
32022-01-26Pfizer-BioNTech No

Free text

Release 11 — days 1–6 daily, dose 3

2022-02-01

Systemic reaction (other): Draining sinus, sneezing

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROParanasal sinus hypersecretion · · ✓
SROSneezing · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…